Flamar; Anne-Laure

Patent Applications and Registrations

Patent applications and USPTO patent grants for Flamar; Anne-Laure.The latest application filed is for "fusion proteins comprising an anti-cd40 antibody and cancer antigens".

Company Profile

6.23.24

Flamar; Anne-Laure - New York NY
Flamar; Anne-Laure - Dallas TX

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods and compositions for treating and preventing HIV Grant 11,219,683 - Levy , et al. January 11, 2	2022-01-11
Fusion Proteins Comprising An Anti-cd40 Antibody And Cancer Antigens App 20210308242 - ZURAWSKI; Gerard ; et al.	2021-10-07
Fusion Proteins Comprising An Anti-cd40 Antibody And Hiv Antigenic Peptides App 20210221904 - ZURAWSKI; Gerard ; et al.	2021-07-22
Fusion proteins comprising an anti-CD40 antibody and HIV antigenic peptides Grant 10,988,544 - Zurawski , et al. April 27, 2	2021-04-27
Fusion proteins comprising an anti-CD40 antibody and cancer antigens Grant 10,980,869 - Zurawski , et al. April 20, 2	2021-04-20
Methods And Compositions For Treating And Preventing Hiv App 20200316191 - LEVY; Yves ; et al.	2020-10-08
Methods and compositions for treating and preventing HIV Grant 10,722,572 - Levy , et al.	2020-07-28
Methods and compositions for treating and preventing HIV Grant 10,610,585 - Levy , et al.	2020-04-07
Methods And Compositions For Treating And Preventing Hiv App 20200101152 - LEVY; Yves ; et al.	2020-04-02
Methods and Compositions for Treating and Preventing HIV App 20190184008 - Levy; Yves ; et al.	2019-06-20
Antigen Presenting Cell Targeted Vaccines App 20180094071 - Zurawski; Gerard ; et al.	2018-04-05
Antigen Presenting Cell Targeted Cancer Vaccines App 20180000916 - Zurawski; Gerard ; et al.	2018-01-04
Antigen presenting cell targeted anti-viral vaccines Grant 9,416,186 - Zurawski , et al. August 16, 2	2016-08-16
Multivariable Antigens Complexed With Targeting Humanized Monoclonal Antibody App 20160031988 - Zurawski; Gerard ; et al.	2016-02-04
Antigen Presenting Cell Targeted Cancer Vaccines App 20160022792 - Zurawski; Gerard ; et al.	2016-01-28
Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells Grant 9,234,040 - Zurawski , et al. January 12, 2	2016-01-12
Antigen Presenting Cell Targeted Vaccines App 20150299329 - Zurawski; Gerard ; et al.	2015-10-22
Dendritic cell-specific antibody conjugate comprising anti-CD40 monoclonal antibodies conjugated to HIV-1 Gag/Nef Grant 9,109,011 - Banchereau , et al. August 18, 2	2015-08-18
Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells Grant 9,102,730 - Zurawski , et al. August 11, 2	2015-08-11
Fusion proteins comprising antibody and HPV E6 and E7 antigens Grant 9,102,734 - Zurawski , et al. August 11, 2	2015-08-11
Anti-CD40 targeted fusion proteins Grant 8,961,991 - Zurawski , et al. February 24, 2	2015-02-24
Vaccines Based On Targeting Antigen To Dcir Expressed On Antigen-presenting Cells App 20140134168 - Zurawski; Gerard ; et al.	2014-05-15
Antigen Presenting Cell Targeted Anti-Viral Vaccines App 20140127198 - Zurawski; Gerard ; et al.	2014-05-08
Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells Grant 8,586,052 - Zurawski , et al. November 19, 2	2013-11-19
Vaccines Based On Targeting Antigen To Dcir Expressed On Antigen-presenting Cells App 20130295120 - Zurawski; Gerard ; et al.	2013-11-07
Fusion protein with HIV antigen Grant 8,518,410 - Zurawski , et al. August 27, 2	2013-08-27
Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells Grant 8,449,888 - Zurawski , et al. May 28, 2	2013-05-28
Vaccines Based on Targeting Antigen to DCIR Expressed on Antigen-Presenting Cells App 20120237513 - Zurawski; Gerard ; et al.	2012-09-20
Novel Vaccine Adjuvants Based on Targeting Adjuvants to Antibodies Directly to Antigen-Presenting Cells App 20120231023 - Zurawski; Gerard ; et al.	2012-09-13
Novel Vaccine Adjuvants Based On Targeting Adjuvants To Antibodies Directly To Antigen-presenting Cells App 20120039916 - Zurawski; Gerard ; et al.	2012-02-16
Vaccines Based on Targeting Antigen to DCIR Expressed on Antigen-Presenting Cells App 20120004643 - Zurawski; Gerard ; et al.	2012-01-05
Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells Grant 8,057,798 - Zurawski , et al. November 15, 2	2011-11-15
Multivariable Antigens Complexed with Targeting Humanized Monoclonal Antibody App 20100330115 - Zurawski; Gerard ; et al.	2010-12-30
Antigen Presenting Cell Targeted Cancer Vaccines App 20100322929 - Zurawski; Gerard ; et al.	2010-12-23
Antigen Presenting Cell Targeted Vaccines App 20100297114 - Zurawski; Gerard ; et al.	2010-11-25
Antigen Presenting Cell Targeted Anti-viral Vaccines App 20100291082 - Zurawski; Gerard ; et al.	2010-11-18
Multivariable antigens complexed with targeting humanized monoclonal antibody Grant 7,786,267 - Zurawski , et al. August 31, 2	2010-08-31
Hiv Vaccine Based On Targeting Maximized Gag And Nef To Dendritic Cells App 20100135994 - Banchereau; Jacques F. ; et al.	2010-06-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.